RU2010147643A - Анализ для детекции гинекологического состояния - Google Patents
Анализ для детекции гинекологического состояния Download PDFInfo
- Publication number
- RU2010147643A RU2010147643A RU2010147643/15A RU2010147643A RU2010147643A RU 2010147643 A RU2010147643 A RU 2010147643A RU 2010147643/15 A RU2010147643/15 A RU 2010147643/15A RU 2010147643 A RU2010147643 A RU 2010147643A RU 2010147643 A RU2010147643 A RU 2010147643A
- Authority
- RU
- Russia
- Prior art keywords
- patient
- condition
- individual
- cancer
- data
- Prior art date
Links
- 238000004458 analytical method Methods 0.000 title claims 12
- 238000001514 detection method Methods 0.000 title claims 2
- 238000000034 method Methods 0.000 claims abstract 22
- 206010028980 Neoplasm Diseases 0.000 claims abstract 18
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims abstract 17
- 201000011510 cancer Diseases 0.000 claims abstract 15
- 201000010099 disease Diseases 0.000 claims abstract 15
- 238000004891 communication Methods 0.000 claims abstract 10
- 238000000491 multivariate analysis Methods 0.000 claims abstract 9
- 230000005540 biological transmission Effects 0.000 claims abstract 2
- 239000000090 biomarker Substances 0.000 claims 9
- 238000012544 monitoring process Methods 0.000 claims 5
- 102000016776 Midkine Human genes 0.000 claims 4
- 108010092801 Midkine Proteins 0.000 claims 4
- 239000000523 sample Substances 0.000 claims 4
- 108090001005 Interleukin-6 Proteins 0.000 claims 3
- 108090001007 Interleukin-8 Proteins 0.000 claims 3
- 206010033128 Ovarian cancer Diseases 0.000 claims 3
- 206010061535 Ovarian neoplasm Diseases 0.000 claims 3
- 108010045517 Serum Amyloid P-Component Proteins 0.000 claims 3
- 101710190759 Serum amyloid A protein Proteins 0.000 claims 3
- 238000002965 ELISA Methods 0.000 claims 2
- 238000002679 ablation Methods 0.000 claims 2
- 238000002512 chemotherapy Methods 0.000 claims 2
- 238000003018 immunoassay Methods 0.000 claims 2
- 239000003446 ligand Substances 0.000 claims 2
- 238000001959 radiotherapy Methods 0.000 claims 2
- 238000003556 assay Methods 0.000 claims 1
- 239000012472 biological sample Substances 0.000 claims 1
- 208000035269 cancer or benign tumor Diseases 0.000 claims 1
- 238000007405 data analysis Methods 0.000 claims 1
- 238000011984 electrochemiluminescence immunoassay Methods 0.000 claims 1
- 239000012634 fragment Substances 0.000 claims 1
- 230000004968 inflammatory condition Effects 0.000 claims 1
- 230000001225 therapeutic effect Effects 0.000 claims 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
- G01N33/57449—Specifically defined cancers of ovaries
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/689—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to pregnancy or the gonads
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
- G16B20/20—Allele or variant detection, e.g. single nucleotide polymorphism [SNP] detection
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/56—Staging of a disease; Further complications associated with the disease
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/60—Complex ways of combining multiple protein biomarkers for diagnosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Physics & Mathematics (AREA)
- Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Biotechnology (AREA)
- Analytical Chemistry (AREA)
- Medical Informatics (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Evolutionary Biology (AREA)
- Theoretical Computer Science (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Bioinformatics & Computational Biology (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicinal Chemistry (AREA)
- Genetics & Genomics (AREA)
- Cell Biology (AREA)
- Microbiology (AREA)
- Food Science & Technology (AREA)
- Biochemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Hospice & Palliative Care (AREA)
- Oncology (AREA)
- Public Health (AREA)
- Bioethics (AREA)
- Artificial Intelligence (AREA)
- Software Systems (AREA)
- Evolutionary Computation (AREA)
- Epidemiology (AREA)
- Databases & Information Systems (AREA)
- Data Mining & Analysis (AREA)
- Computer Vision & Pattern Recognition (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2008902029A AU2008902029A0 (en) | 2008-04-23 | An assay to detect a gynecological condition | |
| AU2008902029 | 2008-04-23 | ||
| AU2008905120A AU2008905120A0 (en) | 2008-10-01 | An assay to detect a gynecological condition | |
| AU2008905120 | 2008-10-01 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| RU2010147643A true RU2010147643A (ru) | 2012-05-27 |
Family
ID=41216335
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2010147643/15A RU2010147643A (ru) | 2008-04-23 | 2009-04-21 | Анализ для детекции гинекологического состояния |
Country Status (14)
| Country | Link |
|---|---|
| US (2) | US20110033377A1 (ko) |
| EP (1) | EP2281200A4 (ko) |
| KR (1) | KR101300694B1 (ko) |
| CN (1) | CN102066939A (ko) |
| AU (1) | AU2009240781B2 (ko) |
| BR (1) | BRPI0911462A2 (ko) |
| CA (1) | CA2725442A1 (ko) |
| CO (1) | CO6311041A2 (ko) |
| GB (1) | GB2464647B (ko) |
| HK (1) | HK1143207A1 (ko) |
| IL (1) | IL208506A (ko) |
| NZ (1) | NZ588406A (ko) |
| RU (1) | RU2010147643A (ko) |
| WO (1) | WO2009129569A1 (ko) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2816339C1 (ru) * | 2023-07-31 | 2024-03-28 | Федеральное государственное бюджетное научное учреждение "Томский национальный исследовательский медицинский центр" Российской академии наук ("Томский НИМЦ") | Способ прогнозирования риска опухолевой прогрессии у больных раком яичников |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3546939A3 (en) * | 2009-12-23 | 2019-11-06 | Cellestis Limited | An assay for measuring cell-mediated immunoresponsiveness |
| CN103038638A (zh) * | 2010-05-07 | 2013-04-10 | Abbvie公司 | 用于预测对用靶向酪氨酸激酶抑制剂治疗的敏感性的方法 |
| KR102022513B1 (ko) * | 2011-06-29 | 2019-09-19 | 셀레스티스 리미티드 | 감도가 증진된 세포 매개 면역 반응 검정법 |
| US20150004633A1 (en) * | 2012-02-07 | 2015-01-01 | Quest Diagnostics Investments Incorporated | Assays and methods for the diagnosis of ovarian cancer |
| WO2017182985A1 (en) * | 2016-04-20 | 2017-10-26 | Morphotek, Inc. | Prognosis of serous ovarian cancer using biomarkers |
| KR101809149B1 (ko) * | 2016-11-25 | 2017-12-14 | 한국과학기술연구원 | 순환계질환 발생잠재도를 판단하는 장치 및 그 방법 |
| US20180173847A1 (en) * | 2016-12-16 | 2018-06-21 | Jang-Jih Lu | Establishing a machine learning model for cancer anticipation and a method of detecting cancer by using multiple tumor markers in the machine learning model for cancer anticipation |
| CN108567413A (zh) * | 2018-03-02 | 2018-09-25 | 黑龙江中医药大学 | 一种医院妇科用多功能的疾病检查设备及检查系统 |
| WO2019241716A1 (en) * | 2018-06-14 | 2019-12-19 | Metabolomycs, Inc. | Metabolomic signatures for predicting, diagnosing, and prognosing various diseases including cancer |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7189507B2 (en) * | 2001-06-18 | 2007-03-13 | Pdl Biopharma, Inc. | Methods of diagnosis of ovarian cancer, compositions and methods of screening for modulators of ovarian cancer |
| US20070042405A1 (en) * | 2003-08-15 | 2007-02-22 | University Of Pittsburgh -Of The Commonwealth System Of Higher Education | Enhanced diagnostic multimarker serological profiling |
| ATE503846T1 (de) * | 2005-09-15 | 2011-04-15 | Val Chum S E C | Verfahren zur diagnose eines ovarialkarzinoms |
| US20080090258A1 (en) * | 2006-06-28 | 2008-04-17 | University Of Pittsburgh -Of The Commonwealth System Of Higher Education | Method and composition for diagnosing endometrial cancer |
| JP2010532484A (ja) * | 2007-06-29 | 2010-10-07 | コレロジック システムズ，インコーポレイテッド | 卵巣癌のための予測マーカー |
-
2009
- 2009-04-21 WO PCT/AU2009/000500 patent/WO2009129569A1/en active Application Filing
- 2009-04-21 GB GB1002660A patent/GB2464647B/en not_active Expired - Fee Related
- 2009-04-21 NZ NZ588406A patent/NZ588406A/en not_active IP Right Cessation
- 2009-04-21 KR KR1020107007802A patent/KR101300694B1/ko not_active IP Right Cessation
- 2009-04-21 CN CN2009801236216A patent/CN102066939A/zh active Pending
- 2009-04-21 BR BRPI0911462A patent/BRPI0911462A2/pt not_active IP Right Cessation
- 2009-04-21 CA CA2725442A patent/CA2725442A1/en not_active Abandoned
- 2009-04-21 US US12/988,622 patent/US20110033377A1/en not_active Abandoned
- 2009-04-21 RU RU2010147643/15A patent/RU2010147643A/ru not_active Application Discontinuation
- 2009-04-21 EP EP09735555A patent/EP2281200A4/en not_active Withdrawn
- 2009-04-21 AU AU2009240781A patent/AU2009240781B2/en active Active
-
2010
- 2010-10-05 IL IL208506A patent/IL208506A/en not_active IP Right Cessation
- 2010-10-13 CO CO10127250A patent/CO6311041A2/es not_active Application Discontinuation
- 2010-10-15 HK HK10109766.1A patent/HK1143207A1/xx unknown
-
2014
- 2014-02-14 US US14/180,833 patent/US20150025810A1/en not_active Abandoned
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2816339C1 (ru) * | 2023-07-31 | 2024-03-28 | Федеральное государственное бюджетное научное учреждение "Томский национальный исследовательский медицинский центр" Российской академии наук ("Томский НИМЦ") | Способ прогнозирования риска опухолевой прогрессии у больных раком яичников |
Also Published As
| Publication number | Publication date |
|---|---|
| EP2281200A4 (en) | 2011-07-06 |
| KR101300694B1 (ko) | 2013-08-26 |
| US20150025810A1 (en) | 2015-01-22 |
| US20110033377A1 (en) | 2011-02-10 |
| WO2009129569A1 (en) | 2009-10-29 |
| CA2725442A1 (en) | 2009-10-29 |
| EP2281200A1 (en) | 2011-02-09 |
| HK1143207A1 (en) | 2010-12-24 |
| GB201002660D0 (en) | 2010-04-07 |
| IL208506A0 (en) | 2010-12-30 |
| IL208506A (en) | 2013-08-29 |
| AU2009240781A1 (en) | 2009-10-29 |
| GB2464647B (en) | 2011-02-16 |
| KR20100126258A (ko) | 2010-12-01 |
| BRPI0911462A2 (pt) | 2015-10-06 |
| CO6311041A2 (es) | 2011-08-22 |
| AU2009240781B2 (en) | 2011-02-17 |
| CN102066939A (zh) | 2011-05-18 |
| GB2464647A (en) | 2010-04-28 |
| NZ588406A (en) | 2012-05-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2010147643A (ru) | Анализ для детекции гинекологического состояния | |
| Edgell et al. | Phase II biomarker trial of a multimarker diagnostic for ovarian cancer | |
| Gao et al. | Correlation between mitochondrial TRAP-1 expression and lymph node metastasis in colorectal cancer | |
| Verburg et al. | Heterophile antibodies rarely influence the measurement of thyroglobulin and thyroglobulin antibodies in differentiated thyroid cancer patients | |
| Tangen et al. | Expression of L1CAM in curettage or high L1CAM level in preoperative blood samples predicts lymph node metastases and poor outcome in endometrial cancer patients | |
| Huang et al. | Preoperative platelet distribution width predicts breast cancer survival | |
| RU2008121754A (ru) | Способы прогнозирования и предсказания рака и мониторинг терапии раковых заболеваний | |
| Wu et al. | Does overexpression of HER-2 correlate with clinicopathological characteristics and prognosis in colorectal cancer? Evidence from a meta-analysis | |
| Ricardo et al. | HER2 evaluation using the novel rabbit monoclonal antibody SP3 and CISH in tissue microarrays of invasive breast carcinomas | |
| Ji et al. | PTEN and Ki67 expression is associated with clinicopathologic features of non-small cell lung cancer | |
| Yang et al. | Preoperative neutrophil-to-lymphocyte ratio is a predictor of survival of epithelial ovarian cancer: a systematic review and meta-analysis of observational studies | |
| Panotopoulos et al. | Elevated serum creatinine and low albumin are associated with poor outcomes in patients with liposarcoma | |
| Yan et al. | Significance of tumour cell HLA‐G5/‐G6 isoform expression in discrimination for adenocarcinoma from squamous cell carcinoma in lung cancer patients | |
| Villalta et al. | Diagnostic accuracy of a new fluoroenzyme immunoassay for the detection of TSH receptor autoantibodies in Graves’ disease | |
| Liu et al. | Different patterns in the prognostic value of age for breast cancer-specific mortality depending on hormone receptor status: a SEER population-based analysis | |
| Gao et al. | Lgr5 over-expression is positively related to the tumor progression and HER2 expression in stage pTNM IV colorectal cancer | |
| RU2015119512A (ru) | Метилглиоксаль в качестве маркера злокачественной опухоли | |
| Pasanen et al. | Preoperative risk stratification of endometrial carcinoma: L1CAM as a biomarker | |
| Shi et al. | Serum HER2 as a predictive biomarker for tissue HER2 status and prognosis in patients with gastric cancer | |
| Masoumi-Moghaddam et al. | Sprouty 1 predicts prognosis in human epithelial ovarian cancer | |
| Lu et al. | High pretreatment plasma D-dimer predicts poor survival of colorectal cancer: insight from a meta-analysis of observational studies | |
| Kornaga et al. | A systematic comparison of three commercial estrogen receptor assays in a single clinical outcome breast cancer cohort | |
| Yu et al. | An algorithmic approach utilizing CK7, TTF1, beta-catenin, CDX2, and SSTR2A can help differentiate between gastrointestinal and pulmonary neuroendocrine carcinomas | |
| Brunette et al. | Validity and prognostic significance of sperm protein 17 as a tumor biomarker for epithelial ovarian cancer: a retrospective study | |
| Teramoto et al. | Risk stratification by quantification of perineural cancer invasion on prostate needle core biopsy: should it be counted? |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA92 | Acknowledgement of application withdrawn (lack of supplementary materials submitted) |
Effective date: 20140303 |